AGP Executive Report
Last update: 12 hours agoDEA Rescheduling Hearing: A long-awaited U.S. DEA hearing on proposed marijuana rescheduling (Schedule I to Schedule III) kicks off Monday, with supporters arguing it better matches medical practice and opponents warning it could expand the commercial market. CBD Legal Pressure: A federal appeals court upheld the DEA’s position that CBD is a Schedule 1 controlled substance, meaning hemp-derived CBD sales must follow state rules or risk federal conflict. Hemp Industry Setback: The same DEA-linked fight has hemp producers vowing to appeal, keeping uncertainty high for retailers and brands. Nigeria Drug Enforcement: NDLEA seized 4,959kg of Canadian “loud” cannabis worth ₦12.4bn at Lagos’s Apapa Port and arrested a China-bound businesswoman with 7.5kg cocaine. Local Drug Harm Push: In Whangārei, a woman is campaigning to stop meth pipes being sold openly in shops, citing legal confusion and youth exposure. Cannabis Business Moves: New York’s first approved cannabis growers showcase drew local farmers, while one town voted against allowing similar events. Industry Capital Signals: Curaleaf CEO Boris Jordan says institutional equity investors are finally willing to talk with cannabis operators, hinting at a potential shift in funding conversations. Wellness Branding: Jamaica’s JACANA launched a Caribbean Wellness Platform, pitching botanical products plus nature-based experiences for the booming wellness-tourism market.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
